Molecular epidemiology of Staphylococcus epidermidis clinical isolates from U.S. hospitals

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 9, 2012, Pages 4656-4661

  Mendes, Rodrigo E ^a   Deshpande, Lalitagauri M ^a   Costello, Andrew J ^a   Farrell, David J ^a  

^a JMI LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID; RNA 23S;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; CLONE; GENE MUTATION; GENE SEQUENCE; HOSPITAL; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; UNITED STATES;

ACETAMIDES; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HOSPITALS; HUMANS; INFANT; MALE; MIDDLE AGED; MULTIGENE FAMILY; MULTILOCUS SEQUENCE TYPING; MUTATION; OXAZOLIDINONES; PHYLOGENY; RNA, RIBOSOMAL, 23S; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; UNITED STATES;

EID: 84865428624     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00279-12     Document Type: Article

References (33)

1. Biedenbach DJ, Farrell DJ, Mendes RE, Ross JE, Jones RN. 2010. Stability of linezolid activity in an era of mobile oxazolidinone resistance determinants: Results from the 2009 Zyvox Annual Appraisal of Potency and Spectrum program. Diagn. Microbiol. Infect. Dis. 68:459-467.
2. Billal DS, Feng J, Leprohon P, Legare D, Ouellette M. 2011. Whole genome analysis of linezolid resistance in Streptococcus pneumoniae reveals resistance and compensatory mutations. BMC Genomics 12:512.
3. Bonilla H, et al. 2010. Multicity outbreak of linezolid-resistant Staphylococcus epidermidis associated with clonal spread of a cfr-containing strain. Clin. Infect. Dis. 51:796-800.
4. Clinical and Laboratory Standards Institute. 2012. M07-A9. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 9th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Clinical and Laboratory Standards Institute. 2012. M100-S22. Performance standards for antimicrobial susceptibility testing: 22nd informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Diaz L, et al. 2012. Transferable plasmid-mediated resistance to linezolid due to cfr in a human clinical isolate of Enterococcus faecalis. Antimicrob. Agents Chemother. 56:3917-3922.
7. Farrell DJ, Mendes RE, Ross JE, Sader HS, Jones RN. 2011. LEADER Program results for 2009: an activity and spectrum analysis of linezolid using 6,414 clinical isolates from the United States (56 medical centers). Antimicrob. Agents Chemother. 55:3684-3690.
8. Gopegui ER, Juan C, Zamorano L, Perez JL, Oliver A. 2012. Transferable multidrug resistance plasmid carrying cfr associated with tet(L), ant(4′)-Ia, and dfrK genes from a clinical methicillin-resistant Staphylococcus aureus ST125 strain. Antimicrob. Agents Chemother. 56:2139-2142.
9. Ibrahem S, Salmenlinna S, Lyytikainen O, Vaara M, Vuopio-Varkila J. 2008. Molecular characterization of methicillin-resistant Staphylococcus epidermidis strains from bacteraemic patients. Clin. Microbiol. Infect. 14:1020-1027. (Pubitemid 352748842)
10. Kosowska-Shick K, Julian KG, McGhee PL, Appelbaum PC, Whitener CJ. 2010. Molecular and epidemiologic characteristics of linezolid-resistant coagulase-negative staphylococci at a tertiary care hospital. Diagn. Microbiol. Infect. Dis. 68:34-39.
11. LaMarre JM, Locke JB, Shaw KJ, Mankin AS. 2011. Low fitness cost of the multidrug resistance gene cfr. Antimicrob. Agents Chemother. 55: 3714-3719.
12. Li M, Wang X, Gao Q, Lu Y. 2009. Molecular characterization of Staphylococcus epidermidis strains isolated from a teaching hospital in Shanghai, China. J. Med. Microbiol. 58:456-461.
13. Liakopoulos A, et al. 2010. Dissemination of two international linezolid-resistant Staphylococcus epidermidis clones in Greek hospitals. J. Antimicrob. Chemother. 65:1070-1071.
14. Locke JB, Hilgers M, Shaw KJ. 2009. Mutations in ribosomal protein L3 are associated with oxazolidinone resistance in staphylococci of clinical origin. Antimicrob. Agents Chemother. 53:5275-5278.
15. Locke JB, Hilgers M, Shaw KJ. 2009. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700). Antimicrob. Agents Chemother. 53:5265-5274.
16. Long KS, Vester B. 2012. Resistance to linezolid caused by modifications at its binding site on the ribosome. Antimicrob. Agents Chemother. 56: 603-612.
17. Marcusson LL, Frimodt-Moller N, Hughes D. 2009. Interplay in the selection of fluoroquinolone resistance and bacterial fitness. PLoS Pathog. 5:e1000541. doi:10.1371/journal.ppat.1000541.
18. Mendes RE, et al. 2010. First report of staphylococcal clinical isolates in Mexico with linezolid resistance caused by cfr: evidence of in vivo cfr mobilization. J. Clin. Microbiol. 48:3041-3043.
19. Mendes RE, et al. 2010. Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy. J. Antimicrob. Chemother. 65:2329-2335.
20. Miragaia M, et al. 2008. Comparison of molecular typing methods for characterization of Staphylococcus epidermidis: proposal for clone definition. J. Clin. Microbiol. 46:118-129.
21. Miragaia M, Thomas JC, Couto I, Enright MC, de Lencastre H. 2007. Inferring a population structure for Staphylococcus epidermidis from multilocus sequence typing data. J. Bacteriol. 189:2540-2552. (Pubitemid 46411368)
22. Sanchez Garcia M, et al. 2010. Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit. JAMA 303:2260-2264.
23. Schoenfelder SM, et al. 2010. Success through diversity: how Staphylococcus epidermidis establishes as a nosocomial pathogen. Int. J. Med. Microbiol. 300:380-386.
24. Schwarz S, Werckenthin C, Kehrenberg C. 2000. Identification of a plasmid-borne chloramphenicol-florfenicol resistance gene in Staphylococcus sciuri. Antimicrob. Agents Chemother. 44:2530-2533. (Pubitemid 30650908)
25. Seral C, et al. 2011. Nosocomial outbreak of methicillin- and linezolid-resistant Staphylococcus epidermidis associated with catheter-related infections in intensive care unit patients. Int. J. Med. Microbiol. 301:354-358.
26. Shaw KJ, Barbachyn MR. 2011. The oxazolidinones: past, present, and future. Ann. N. Y. Acad. Sci. 1241:48-70.
27. Thomas JC, et al. 2007. Improved multilocus sequence typing scheme for Staphylococcus epidermidis. J. Clin. Microbiol. 45:616-619.
28. Toh SM, et al. 2007. Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid. Mol. Microbiol. 64:1506-1514.
29. Vuong C, Otto M. 2002. Staphylococcus epidermidis infections. Microbes Infect. 4:481-489. (Pubitemid 34270685)
30. Wang Y, et al. 2011. Detection of the staphylococcal multiresistance gene cfr in Proteus vulgaris of food animal origin. J. Antimicrob. Chemother. 66:2521-2526.
31. Widerstrom M, et al. 2009. Clonality among multidrug-resistant hospital-associated Staphylococcus epidermidis in northern Europe. Scand. J. Infect. Dis. 41:642-649.
32. Wong A, et al. 2010. Polyphyletic emergence of linezolid-resistant staphylococci in the United States. Antimicrob. Agents Chemother. 54:742-748.
33. Ziebuhr W, et al. 2006. Nosocomial infections by Staphylococcus epidermidis: how a commensal bacterium turns into a pathogen. Int. J. Antimicrob. Agents 28(Suppl. 1):S14-S20.